Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Submitted by
admin
on June 4, 2012 - 6:02pm
Source:
Bloomberg
News Tags:
GSK
melanoma
dabrafenib
trametinib
Headline:
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Do Not Allow Advertisers to Use My Personal information
